Sharon E. Frey

Infectious Disease

3635 Vista Ave
Saint Louis, MO 63110

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 97 publications

Digital therapeutics for depression in Germany: A systematic app review.

Digital therapeutics for depression in Germany: A systematic app review.

Journal: Internet interventions

Published: June 08, 2026

Vaccinia virus and Monkeypox virus neutralizing and antigen-binding antibodies following subcutaneous and reduced intradermal doses of an MVA vaccine.

Vaccinia virus and Monkeypox virus neutralizing and antigen-binding antibodies following subcutaneous and reduced intradermal doses of an MVA vaccine.

Journal: Vaccine

Published: February 19, 2026

The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances.

The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances.

Journal: Vaccine

Published: October 31, 2025

From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation Units.

From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation Units.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 10, 2025

Vaccine and Treatment Evaluation Units: A Historical Perspective.

Vaccine and Treatment Evaluation Units: A Historical Perspective.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 10, 2025

Emerging and Pandemic Pathogens: Lessons Learned From a Clinical Research Network.

Emerging and Pandemic Pathogens: Lessons Learned From a Clinical Research Network.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 10, 2025

Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination.

Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination.

Journal: Vaccine

Published: May 27, 2025

Differences in Mpox and Vaccinia Immunity Induced by Non-Replicating and Replicating Vaccinia-Based Vaccines.

Differences in Mpox and Vaccinia Immunity Induced by Non-Replicating and Replicating Vaccinia-Based Vaccines.

Journal: Vaccines

Published: March 19, 2025

Optimizing Microneutralization and IFN-γ ELISPOT Assays to Evaluate Mpox Immunity.

Optimizing Microneutralization and IFN-γ ELISPOT Assays to Evaluate Mpox Immunity.

Journal: Vaccines

Published: November 22, 2024

A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45 years of age.

A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45 years of age.

Journal: Vaccine

Published: November 08, 2024

Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens.

Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens.

Journal: Vaccine

Published: October 28, 2024

Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®.

Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®.

Journal: Vaccine

Published: October 07, 2024

Showing 1-12 of 97

Last Updated: 09/26/2026